Thyroid hormones regulate critical developmental processes and key metabolic pathways. A number of natural and synthetic substances have been identified which adversely interfere with the endocrine system. These so-called endocrine disrupters (ED) have mainly been studied for their impact on the gonadal hormone axis. The aim of this work was to develop a novel sensitive and convenient in vitro screening assay for the detection and characterization of potential ED of thyroid hormone (TH)-dependent transactivation of gene transcription and to apply this tool to test relevant environmental and nutritive ED compounds. We constructed a TH-responsive luciferase-based reporter plasmid and established a reporter gene assay in a 96 well microplate format using the human hepatocarcinoma cell line HepG2 as host system. Both the synthetic TH receptor (TR) agonist GC-1 and the antagonist NH-3 were used to evaluate the assay. Concentrationresponse data of test compounds (food constituents, isoflavones, ultraviolet-absorbers, pesticides, industrial chemicals) were recorded in activation assays. In addition, interference with THmediated transactivation was tested by coincubation of the ED with triiodothyronine (T 3 ) in competition assays. Most ED tested affected T 3 reporter gene activity at concentrations of 1mM or higher and displayed either agonistic or mixed agonistic/antagonistic activities. Effects of relevant ED occurred only at relatively high concentrations compared with the endogenous TR ligand T 3 . However, on basis of their high production volumes and potential bioaccumulation of some fat-soluble ED our data indicate the need to carefully monitor certain ED for potential disruption of the TH system in intact organisms and humans.
The endocrine system of vertebrates controls central developmental and metabolic processes during growth, maturation and differentiation. Disruption of endocrine signaling may result in severe consequences for health and well-being of the organism. An endocrine disruptor is an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations'' (definition according to the World Health Organization, 2002) .
The thyroid hormone (TH) system with its main hormones tetraiodo-L-thyronine (T 4 ) and the physiologically active 3,3#,5-triiodo-L-thyronine (T 3 ) are crucial regulators of many developmental processes (e.g., brain, inner ear and bone development as well as bone remodeling) and physiological functions such as carbohydrate-, lipid-, and protein metabolism and homeostasis of the metabolic rate (Oetting and Yen, 2007) . Severe T 3 -deficiency during gestation leads to severe mental retardation and growth defects of the offspring pointing to the importance of T 3 in regular development (Bernal, 2005) . In the adult organism T 3 plays a critical role in metabolic homoeostasis, heart function, and the psychoneurological well being (Bauer and Whybrow, 2001) . Therefore, the normal function of the TH system has a pivotal biological, medical and social significance (Köhrle, 2008) . THs are produced in the thyroid gland under control of thyroid stimulating hormone (TSH) (Zoeller et al., 2007) . T 4 and to a lesser extent T 3 are secreted into the blood stream where they are bound by the TH distribution proteins thyroxine-binding globulin (TBG), transthyretin (TTR), and albumin (Richardson, 2007) . Deiodinases, intracellular selenoenzymes, convert T 4 to the active T 3 by 5#-deiodination thereby controlling the local availability of T 3 for cellular action (Köhrle, 2007) .
T 3 exerts its main biological activity via T 3 receptors (TRs) which are ligand modulated transcription factors of the nuclear receptor superfamily (Oetting and Yen, 2007) . Two genes, THRA and THRB, encode for TR and by alternate promoter usage and alternative splicing give rise to several TR isoforms and isotypes (Zoeller et al., 2007) . TRa 1 and TRb 1 are the bestcharacterized major forms which bind T 3 and DNA (Oetting and Yen, 2007) . They both have a similar affinity for T 3 (10 À9 -10 À10 M) and transactivate target gene transcription in a concentration-dependent manner (Zoeller et al., 2007) . TR bind specific DNA-motives mainly in the promoter region of their target genes, the T 3 response elements (TREs), via their DNAbinding domain (Harbers et al., 1996) . Classical TRE consist of two hexamer ''half-sites'' with the consensus sequence AGGT(C/A) A spaced by four nucleotides (Oetting and Yen, 2007) .
Previous in vivo experiments revealed thyroid disrupting effects of several substances contained in products of daily life, nutrients, or environmental contaminants but so far the underlying mechanisms remain largely unresolved . Environmental chemicals may functionally disrupt the TH system by influencing different steps such as synthesis, secretion, action and metabolism (Brucker-Davis, 1998 ). Some EDs have been shown to interfere with iodide uptake via the Na þ /I À symporter (Schröder-van der Elst et al., 2004; Wolff, 1998) , with TH-binding to serum TTR (Lans et al., 1993) , by inhibiting the thyroid peroxidase (TPO) (Doerge and Chang, 2002) or by inhibiting the deiodinase type I (DIO1) (Capen, 1994) . To date little is known about the mechanism of endocrine toxicity exerted by ED regarding the most central endpoint of the TH-system namely the T 3 /TRmediated target gene transcription. Therefore, a novel assay was developed and optimized for the rapid in vitro screening of ED-effects on TR mediated transcription of T 3 target genes.
The original selection of ED classes tested here was based on an agreement and negotiations of the EURISKED consortium with the EU commission (www.eurisked.org). Test compounds were chosen according to their expected relevance for human health. Criteria to include a compound were mass production, human exposure, and chemical relationship to natural hormones or previously observed adverse effects in vivo. We selected environmental chemicals contained in food, UV-filters used in cosmetics and plastics, pesticides, and industrial chemicals such as plasticizers, detergents or flame retardants. An overview of the test compounds and their structural formulas are given in Table 1 and in Table 2 human exposition data for certain ED are summarized.
MATERIAL AND METHODS
Chemicals. For abbreviations and details on chemicals see Table 1 . T 3 (purity ! 97%), 4-Nonylphenol (4NP, analytical standard), Apigenin (API, purity ! 95%), Acetochlor (ACETO, analytical standard), Benzophenone-2 (BP2, purity 97%), Benzophenone-3 (BP3, purity 98%), Genistein (GEN, purity ! 98%), Hispidulin (HIS, purity ! 98%), Linuron (LIN, analytical standard), Myristicin (MYR, purity ! 97%), Naringenin (NAR, purity 98%), Nitrofen (NIT, analytical standard), Procymidone (PRO, analytical standard), Resveratrol (RES, purity > 99%), Silymarin (SIL, standardized mixture), and Tetrabromobisphenol A (TBBPA purity 97%) were obtained from Sigma-Aldrich (Taufkirchen, Germany); 4-methylbenzylidene camphor (4MBC, purity ! 99%), Bisphenol A (BPA, purity ! 97%), and Octylmethoxycinnamate (OMC, purity ! 98%) were from Merck KGaA (Darmstadt, Germany), Dibutylphthalate (DBP, purity 99%) was from MP Biomedicals Europe (Illkirch, France); 3,3#,5-Triiodo-thyroacetic acid (TRIAC, purity ! 99%) was provided by Dr Thoma (Formula, Berlin, Germany), GC-1 and NH-3 were a gift from Prof. Dr Scanlan (OHSU, Portland, OR), F21388 (purity ! 99%) was synthesized by Prof. Dr Schreier (Universität Würzburg, Germany) and Xanthohumol (XN, purity ! 95%) was obtained from Prof. Dr Becker (Saarbrücken, Germany). Stock solutions of 10mM T 3 and TRIAC were prepared in 40mM NaOH and serial dilutions in plain DMEM (Dulbecco's modified Eagle's medium) w/o phenol red (Invitrogen, Karlsruhe, Germany) were prepared freshly on each experimental day. The remaining test compounds were dissolved in DMSO Hybri-Max grade (Sigma-Aldrich). Its final concentration in cell culture medium was adjusted to 0.05% DMSO (vol/vol) by serial dilution in DMEM w/o phenol red.
Plasmids. The sequence of the TRE for the T 3 reporter gene plasmid was chosen according to publications on optimized synthetic TRE (Fig. 1A) . The upstream half-site with the consensus TRE sequence (AGGTCA) was extended at the 5# terminus by the two nucleotides TA (Katz and König, 1994) , the four spacer nucleotides between two half-sites were chosen to be CTTC (Harbers et al., 1996) and the two downstream nucleotides of the second half-site (AGGTCA) were chosen to be CT (Quack et al., 2002) . Oligonucleotides with the sequence 5#-GATCCTAAGGTCACTTCAGGTCACTG-3# (sense) and 5#-GATCCAGTGACCTGAAGTGACCTTAG-3# (antisense) were synthesized by MWG-Biotech (Ebersberg, Germany) and hybridized to generate doublestranded DNA with BamHI cohesive ends and harboring two TRE half-sites (bold and italicized). These DNA-fragments were self-ligated to obtain new double-stranded DNA consisting of two of the original fragments and containing four TRE half-sites. After filling in the 3#-cohesive ends using Taq-Polymerase (Promega, Mannheim, Germany) the product was inserted into the plasmid pGEM-T Easy (Promega). The primers 5#-TAATACGACTCAC-TATAGG-3# (T17, sense) and 5#-ATTTAGGTGACACTATAG-3# (SP6, antisense) were utilized to amplify the insert of the pGEM-T Easy construct in a PCR step with Pfu-polymerase (Promega). The amplicon was subcloned into the SmaI site of pGL3-Promoter (Promega) to generate the T 3 -reporter gene plasmid p(DR4)2-SV40-lucþ which contains two DR4 (direct repeat TRE with a spacer of 4 base pairs) elements. The TR expression plasmids pRS-TRa 1 (Thompson and Evans, 1989 ) and pRS-TRb 1 (Weinberger et al., 1986) were kind gifts from Drs Thompson and Weinberger, respectively. Cells. The human hepatocarcinoma cell line HepG2, embryonic kidney fibroblast cell line HEK-293, colon carcinoma cell line Caco-2 and the monkey kidney cell line Cos-7 were obtained from ATCC. The human follicular thyroid carcinoma cell lines FTC-133 and FTC-238 were obtained from Dr Goretzki (Goretzki et al., 1989) . FTC-133, FTC-238 and HepG2 cells were routinely grown in 75-cm 2 flasks under 10% CO 2 humidified atmosphere at 37°C in Dulbecco's modified Eagle's medium/Ham's F12 nutrient mix (1:1) containing 4.5 g/l glucose (DMEM/F12) and 10% fetal bovine serum (FBS). Caco-2, Cos-7, and HEK-293 cells were grown under the same conditions except for the culture medium which was DMEM containing 4.5 g/l glucose and 10% FBS. Standard media and supplements were from Invitrogen and sterile cell culture plastics from TPP (Trasadingen, Switzerland). Special media for serum-free cell culture were bought from Cambrex Bio Science (Verviers, Belgium). Charcoal/Dextran treated FBS from HyClone for experiments with hormonereduced serum was obtained from Thermo Scientific (Bonn, Germany).
T 3 reporter gene assays. For each experiment, 2.4Áx 10 7 HepG2 cells were seeded into T150 flasks and grown over night (Fig. 1B) . The cells were transfected with 45 lg p(DR4) 2 -SV40-lucþ and 15 lg pRS-rTRa 1 or pRShTRb 1 using the PolyFect reagent (Qiagen, Hilden, Germany). After 8 h incubation the transfected cells (1 3 10 5 cells per well) were transferred into white 96-well luminescence plates (Nunc, Wiesbaden, Deutschland) and incubated for 16 h in DMEM/F12 containing 10% FBS. Then cells were washed and incubated in DMEM w/o phenol red and containing no FBS for one hour. The medium was exchanged for fresh plain DMEM w/o phenol red and the cells of separate culture wells were incubated with different concentrations of test compounds ranging from 10 À11 to 10 À5 M, or with solvent control (0.05% DMSO in DMEM w/o phenol red) for 24 h. The screening of ED was carried out in two types of assays, an activation assay and a T 3 -competition assay. For activation assays, the cells of different culture wells were exposed to a range of the test compound concentrations alone. In competition assays, the cells of separate culture wells were incubated with different concentrations of test substances in presence of 1nM T 3 . Lysis of cells was done directly in culture plates by applying 20 ml of passive lysis buffer (Promega) and shaking on a microplate shaker for 15 min at ambient temperature. The luciferase assays were carried out using the luciferase assay Cell viability assays. HepG2 cells were seeded at a density of 1 3 10 4 cells per well of a white, opaque 96-well cell culture plate. After 24 h, the cells were treated in quadruplicate culture wells as described for the T 3 reporter gene assay. The cell viability assay CellTiter-Glo (Promega) was performed according to the manufacturer.
RNA isolation and quantification. HepG2 cells were cultured in six-well plates until subconfluency for quantitative RNA analyses. Cells were washed in serum-free culture medium for one hour and incubated with different concentrations of test compounds in serum-and phenol red-free DMEM for 24 h. For T 3 -competition experiments, the cells were preincubated with the test compounds for one hour before the addition of 1nM T 3 . Total RNA from cells was isolated using the RNeasy Mini Kit from Qiagen (Hilden, Germany) according to the manufacturer's recommendations. Transcript concentrations of DIO1, 18S rRNA (18S), b-actin (ACTb), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1) were determined by quantitative real-time polymerase chain reaction (qRT-PCR) analysis. Briefly, cDNA was synthesized from 1 lg of total RNA using the first-strand cDNA synthesis kit iScript (Bio-Rad, München, Germany). Primers were chosen with the help of Primer3 (http:// www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). The primer FIG. 1. Scheme of the T 3 reporter plasmid and the reporter assay. The T 3 reporter plasmid p(DR4) 2 -SV40-lucþ and the constructed TRE are displayed in (A). The optimized multiwell screening assay protocol (B) starting with the seeding of human HepG2 cells in T150 culture vessels and their transfection with the reporter plasmid and cotransfection of a TR expression plasmid the next day is schematically depicted. The transfected cells (1 3Á10 5 cells per well) were transferred into the culture wells of white 96-multiwell plates after 8 h. After 16 h, the cells were washed with serum-free DMEM containing no phenol red for 1 h. For activation assays the cells were then incubated with increasing concentrations of the test substances alone for 24 h. For competition assays increasing concentrations of test substances were coincubated in presence of 1nM T 3 for 24 h. Afterwards the luciferase assays were carried out directly in the cell culture wells yielding the transactivation readouts. DR4 2 : two DR4 half-sites; SV40: SV40 promoter; lucþ: codon-optimized firefly luciferase gene. ENDOCRINE DISRUPTERS OF THE THYROID AXIS sequences were DIO1-f: 5#-TTGACCAGTTCAAGAGGCTTAT-3#; DIO1-r: 5#-TGATTTCTGATGTCCATGTTGT-3#; 18S-f: 5#-TTGACGGAAGGG-CACCACCAG-3#; 18S-r: 5#-GCACCACCACCCACGGAATCG-3#; ACTbf: 5#-CACCACACCTTCTACAATGAGC-3#; ACTb-r: 5#-CAGAGGCGTA-CAGGGATAGC-3#; GAPDH-f: 5#-TCTCTGCTCCTCCTGTTCG-3#; GAPDH-r: 5#-TGGCAACAATATCCACTTTACC-3#; HPRT1-f: 5#-TGA-CACTGGCAAAACAATGCA-3#; HPRT1-r: 5#-GGTCCTTTTCACCAG-CAAGCT-3#. Amplifications were conducted in duplicate with the Absolute qPCR SYBR Green Fluorescein Mix (ABgene House, Epsom, UK) on a RT-PCR detection system (iCycler; Bio-Rad). Specificity of the amplification products was verified by melting curve analyses and analytical gel electrophoresis.
Statistical analysis. Concentration-response curves were analyzed using GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, CA, www.graphpad.com) to obtain EC 50 and IC 50 values. Data are shown as mean ± standard error of the mean (SEM). One-way ANOVA with Dunnett's post-test was performed to compare statistical means and to determine the lowest observed effective concentration (LOEC). P < 0.05 was considered significant. For the calculation of fold-change values each value of the treatment groups was divided by the mean value of the respective control group. qRT-PCR data were calculated using the Relative Expression Software Tool (REST, 2008, version 2.0.7, Qiagen, Hilden, Germany) as described elsewhere (Pfaffl et al., 2002) with the combination of 18S, GAPDH, HPRT, and ACTb as a combined internal standard. Relative mRNA concentrations are expressed as means þ SEM.
RESULTS

Optimization of the T 3 Reporter Assay
Several human cell lines were evaluated regarding their suitability for this new T 3 reporter luciferase assay detecting ED activity of test compounds (Supplementary Table 1 ). Some cells did not respond to T 3 in absence of TR transfection (HEK293), whereas others displayed an intermediate response . The strongest luciferase induction was achieved using HepG2 cells (4.7-fold). Cotransfection with TRa 1 led to an augmented response in all cell lines ranging from 1.7-fold (FTC-133) up to 32-fold with HepG2 cells (Supplementary Table 1 ). Based on this observation we chose HepG2 cells as our routine cell model. Time-course experiments revealed a maximal response after 24 h of incubation with T 3 (Supplementary Fig. 1 ) and therefore all following readouts were obtained after 1 day of T 3 or ED exposure. Confluent transfected HepG2 cells were incubated with several media of different formulations for 24 h and a luciferase assay was performed to determine which cell culture medium yields minimal background. Minimal background was achieved using serum-free DMEM not containing phenol red (Supplementary Table 2 ). Media especially formulated for serum-free culture conditions (ProCHO-AT CDM, UltraCHO, Ultra-CULTURE [Cambrex Bio Science, Verviers, Belgium]) yielded the highest background. The use of DMEM containing 10% charcoal-dextran treated FBS resulted in only marginal lower background than using DMEM containing 10% FBS. The optimal cell number of transfected HepG2 cells to be transferred per well into the 96-well cell culture plates was determined by seeding increasing numbers ranging from 10 4 to 10 5 transfected HepG2 cells into a 96-well plate and incubating them in presence or absence of 100nM T 3 for 24 h. A subsequent luciferase assay revealed a maximum induction with 10 5 transferred HepG2 cells ( Supplementary Fig. 2 ).
Effects of T 3 and TRIAC on the Assay
In cotransfection experiments with TRa 1 the sigmoidal concentration-response curve of T 3 was characterized by a LOEC of 10 À10 M and a maximal induction of 122-fold at a concentration of 10 À7 M as compared with solvent control (Fig. 2A) . Nonlinear regression revealed an EC 50 of 1.2nM. The concentration-response curve of TRb 1 -cotransfected HepG2 cells was comparable with respect to EC 50 and LOEC but the maximal induction was 5.6 times lower than the value obtained after cotransfection of TRa 1 (Fig. 2B) . TRIAC, a natural TH metabolite, yielded a maximal induction of 59-fold at a concentration of 1lM, the LOEC was 10 À9 M (Table 3 ) and the EC 50 50nM (Supplementary Fig. 3 ).
FIG. 2.
Concentration-response curves of T 3 in TRa 1 -and TRb 1 -cotransfected cells. HepG2 cells were transfected with p(DR4)-2 -SV40-lucþ and either pRSTRa 1 (A) or pRS-TRb 1 (B) and incubated in the presence of rising T 3 concentrations for 24 h under serum-free conditions. The relative light units (RLU) measured in the solvent control (SC) was set to 0% and the maximal RLU was set to 100% and plotted versus the T 3 concentration. Data represent mean ± SEM of three independent experiments with quadruplicate cell culture wells for (A) and mean ± SEM of one experiment with quadruplicate cell culture wells for (B). The maximal induction as compared with SC is given as ''max. ind.'' Nonlinear regression and the EC 50 values were calculated using Graphpad Prism 4. The LOEC value indicates the lowest concentration that was statistically significantly different from the SC (p < 0.05; ANOVA, Dunnett's test).
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Assay Evaluation Using Synthetic TR Agonists or Antagonists
The synthetic TR agonist GC-1 (Chiellini et al., 1998) and the T 3 antagonist NH-3 (Lim et al., 2002) were used to evaluate the assay for screening of endogenous substances interfering with T 3 -mediated transcription. In the activation assay (in the absence of T 3 ) the sigmoidal GC-1 concentrationresponse curve was defined by an EC 50 of 22nM, a LOEC of 10 À9 M and a maximal induction of 80-fold over solvent control values (Fig. 3A) . With TRb 1 cotransfection we observed an EC 50 value of 0.7nM and a maximal induction of 19-fold ( Supplementary Fig. 4 ). In the competition assay in presence of 1nM T 3 the LOEC of GC-1 was shifted to 10 À8 M, the EC 50 was 24nM and maximum induction was threefold higher as the solvent control containing 1nM T 3 exclusively (Fig. 3B) . In the activation assay the ''T 3 -antagonist'' NH-3 induced the reporter gene at with a LOEC of 5Áx 10 À7 , a maximum induction of 2.6-fold as compared with solvent control at 10 À5 M and an EC 50 of 81nM (Fig. 3B) . However, an antagonistic effect of NH-3 was observed in competition with 1nM T 3 . Here NH-3 acted antagonistically at a LOEC of 5Áx 10 À8 M and an IC 50 of 100nM was determined. A maximal repression of reporter gene transcription was observed at a concentration of 1Áx 10 À6 M (Fig. 3D) .
Screening of ED for Agonistic and Antagonistic Effects
TBBPA represents a compound which is known to have antithyroidal effects on T 3 -dependend transcription in amphibians and in cell culture (Jagnytsch et al., 2006 (Jagnytsch et al., , 2007 . It was antagonistic in the competition assay in concentrations starting from 1lM (Fig. 4A ) but displayed also agonistic effects at 10lM on the reporter gene expression. The synthetic flavonoid F21388 also acted as a mixed agonist/antagonist (Fig. 4B ). F21388 concentrations of 100nM and higher induced the reporter gene transcription in the activation assay and concentrations over 3lM repressed reporter activity in competition assays. The UVabsorber 4MBC stimulated reporter transcription in the 
[: induction; Y: repression; -: no statistically significant effect; ND: not determined.
ENDOCRINE DISRUPTERS OF THE THYROID AXIS
activation assay with a LOEC of 1lM and acted antagonistically in the competition assay at a concentration of 10lM (Fig. 4C) . Another UV-screen, that is, BP2 was activating at a concentration of 1lM and higher in both assays yielding inductions of 1.8-fold and 1.4-fold in activation and competition assays, respectively. Data for the other ED compounds tested are summarized in Table 3 .
Analysis of DIO1 as Endogenous T 3 Target Gene
The influence of the test compounds on the expression of endogenous T 3 target genes was studied by qRT-PCR analyses. DIO1 was identified as the most robust T 3 target gene in HepG2 cells of 11 potential target genes analyzed (data shown for DIO1 only). T 3 -concentrations ranging from 1nM to 1lM as well as 1lM GC-1 resulted in a threefold induction of DIO1 expression (Fig.  5A ). BP2 (10lM) had no significant effect but F21388 and TBBPA decreased and 4MBC increased DIO1 expression significantly (Fig.  5A) . Coincubation of NH-3 with 1nM T 3 led to a highly significant decrease of DIO1 expression compared with the effect of 1nM T 3 alone (Fig. 5B ). F21388 and 4MBC were without effect in these T 3 competition experiments, but 10lM TBBPA decreased the T 3 -dependent induction of DIO1 expression (Fig. 5B) .
DISCUSSION Assay Establishment and Optimization
For the construction of a most suitable T 3 reporter gene plasmid we designed a bona fide DR4 based on previous optimization of TRE (Harbers et al., 1996; Katz and König, 1994; Quack et al., 2002) . HepG2 revealed the strongest T 3 response among several human and one monkey kidney cell line. The fact that liver is a major target organ of T 3 metabolism and action provided further arguments to adapt the reporter assay to HepG2 cells. Cotransfection with TR expression plasmids, especially TRa 1 , clearly enhanced the T 3 response of HepG2 cells as compared with single transfections with the T 3 reporter gene construct alone relying on the endogenous TR solely. Consequently, we routinely employed TR-cotransfection to markedly increase the dynamic range and the maximal induction (122-fold induction, Table 3 ). There are three main reasons for using serum-free DMEM as incubation medium of choice: Firstly, some test compounds bind serum TH binding proteins such as TBG or TTR (Radovic et al., 2006) thus influencing free ED concentrations. Secondly, a byproduct of phenol red production (bis(4-hydroxyphenyl)[2-(phenoxysulfonyl)phenyl]methane) is known to exert ED-like activity by itself (Bindal and Katzenellenbogen, 1988) . And thirdly, serum-free DMEM without phenol red clearly produced the lowest background (Supplementary Table 2 ) offering the potentially widest dynamic range. In our assay TRa 1 -cotransfected HepG2 clearly outperformed cells cotransfected with TRb 1 or previously reported systems that did not exceed 25-fold inductions (Jugan et al., 2007) . In consequence, the substantially larger signal amplitudes of the TRa 1 -based assay with over 100-fold induction efficiencies are well suited to detect potentially moderate effects to be expected from even weak ED.
Assay Evaluation Using Established TR Agonists and Antagonists
To evaluate the suitability of this hepatocyte-based assay system for detecting effects of compounds interfering with T 3 / TR-mediated transactivation we employed the synthetic TR FIG. 5 . Effects of selected ED on the endogenous T 3 target gene DIO1 expression. HepG2 cells were grown in six-well plates until 80% confluency was obtained. Then the cells were washed and incubated with the test compounds in serum-and phenol red-free DMEM in absence or presence of 1nM T 3 for 24 h. Total RNA was isolated and qRT-PCR was carried out. Data represent the mean of three biological and two technical replicates þ SEM. Statistical significance was calculated using the software tool REST 2008 (Pfaffl et al., 2002 ). *p < 0.05, **p < 0.01, ***p < 0.001. ENDOCRINE DISRUPTERS OF THE THYROID AXIS agonist GC-1 and the antagonist NH-3 (Chiellini et al., 1998) . We confirmed in our hepatocyte-based reporter system that GC-1 behaves as a pure agonist as described earlier (Chiellini et al., 1998) . As expected, NH-3 acted as an antagonist in the competition assay. Noteworthy, we also observed a slight agonistic effect when NH-3 was incubated alone in absence of T 3 . Because of the small potency of this ''agonistic'' effect it is conceivable that NH-3 was previously classified exclusively as a pure antagonist (Nguyen et al., 2005) . At similar concentrations as in our hepatocyte assay, NH-3 displayed agonistic effects in a TH-dependent endpoint analysis in an amphibian metamorphosis model . In conclusion, the dynamic response and the reference substances tested proved this new in vitro reporter assay a suitable tool for the sensitive detection and quantification of both agonistic and antagonistic effects of ED test compounds on T 3 -dependent transactivation.
Screening of ED for Interference with TR-Dependent Transactivation
Flame retardants like TPPBA are of significant importance in the modern society and help to safe life. But due to their chemical properties they accumulate in environment and food chains and a wide spectrum of toxic effects was detected in experimental animals models (Kuriyama et al., 2005) . TBBPA has one of the highest production volumes of all flame retardants (> 60,000 tons per year) and can be found in human serum in the range of 0.4-3.3 ng/g lipids (Thomsen et al., 2002) . Because of its structural relationship to T 4 , TBBPA was suspected to influence the TH-system by interference with T 4 binding to TTR (Meerts et al., 2000) . Moreover, it binds TR directly and impairs TH-dependent metamorphosis in amphibian models (Jagnytsch et al., 2006) . TBBPA also interferes with T 3 /TR-mediated transcription in transactivation assays (Jugan et al., 2007) . We reproduced the latter observations with our ED screening system. No adverse effects of TBBPA in concentrations up to 10lM were detected in the HepG2 cell viability assay (Table 3) , but data from others point to negative effects in certain cell lines with IC 50 > 50lM (Strack et al., 2007) . For the chemicals examined in our study this observation supports our strategy to limit the ED concentrations to a maximum concentration of 10lM to distinguish cytotoxic from endocrine disrupting effects.
F21388 is a synthetic flavonoid initially generated as a T 4 analog (Köhrle et al., 1988) . It displaces T 4 from binding to TTR at nanomolar concentrations, interferes with the TSH feedback regulation and inhibits DIO1 (Radovic et al., 2006) . The present work shows that F21388 also acts as a mixed agonist/antagonist on TR-mediated transactivation. Especially, its antagonistic effect was quite pronounced with an IC 50 value of 3.1lM. This observation suggests a multiple mode of synergistic F21388 action on TH serum binding, intracellular metabolism and nuclear TR modulation, compatible with its marked in vivo effects on TH homeostasis and action in rodent models (Pedraza et al., 1996) . UV-absorbers widely applied in sunscreens and as photo protection additives in common cosmetics and plastic materials represent a daily source of exposition to ED. Due to the growing awareness of the risks exerted by exposure to UV light, for example, skin ageing, skin damage, and skin cancer, an increased use of UV-filters is promoted. 4MBC is used in concentrations of up to 6% (wt/wt) in sunscreens, deodorants and shampoos (Janjua et al., 2007) . Transdermal absorption of 4MBC and final plasma concentrations of 80nM (Janjua et al., 2004) and 200nM (Schauer et al., 2006) , respectively were reported. We did not detect effects of 4MBC at corresponding nanomolar concentrations but the LOEC of 4MBC (1lM) was close to the concentrations reported. Parallel in vivo experiments with rats showed additional effects of 4MBC on TH production and homeostasis (Schmutzler et al., 2004 . Another UV-absorber, BP3, easily penetrates human skin resulting in plasma concentrations of 1.3lM (Janjua et al., 2004) . It has recently been detected in the majority of urine samples with maximum concentrations higher than 1lM (Calafat et al., 2008a) . In this context our finding that BP3 acted as a slight TR agonist in micromolar concentrations (Table 3 ) seems to be of importance. BP2 is structurally closely related to BP3 and also acted as a pure agonist at a concentration of 1lM. Therefore, it might be speculated that this effect observed here is of human relevance especially with respect to an expected bioaccumulation of BP2 in lipid-rich tissues. This would lead to relevant albeit weak induction of T 3 target genes if not compensated for by the endocrine feedback system. Another important activity exerted by BP2 is its very potent inhibition of TPO associated with reduced T 4 and increased serum TSH concentrations in rats .
Some of the additionally tested ED compounds are already known to exert thyroid disrupting effects in vivo and were active in this in vitro screening assay, too. For example the UV-absorber OMC disrupts the TH-axis in mice and acted agonistically in our T 3 reporter assay at micromolar concentrations (Table 3) , but animal exposure data have not been correlated. The industrial chemical BPA acts as a T 3 antagonist in Xenopus laevis (Fini et al., 2007) and as a mixed agonist/antagonist at micromolar concentrations in our assay (Table 3 ). The LOEC of BPA detected in our assay is close to the maximal concentrations detected in human blood samples (Calafat et al., 2008b) and might therefore be an additional cause of concern independent of its effects on the reproductive hormone system. 4NP, a chemical used as detergent and plasticizer, reduced thyroid weights in rats (Woo et al., 2006) and inhibited TPO in vitro with an IC 50 of 57lM (Schmutzler et al., 2004) . 4NP acted as a mixed agonist/ antagonist in our T 3 reporter gene assay (Table 3) , but further studies are required to identify any exposure-related thyroid axis disruption. GEN is the major isoflavone contained in soy beans and therefore also in many food products based on soy. It acted agonistically at micromolar concentrations in the T 3 -reporter assay. These concentrations appear to be relevant for 134 human health because isoflavone concentrations in the micromolar range have been detected in human blood (Doerge and Sheehan, 2002) .
In order to test whether the effects observed in the reporter assay are paralleled by changes in the expression of endogenous target genes, we have analyzed 11 potential T 3 -target genes. DIO1 turned out to represent the most reliable and sensitive endogenous hepatic T 3 target. Because this enzyme is critically important for intracellular T 4 to T 3 conversion and thyroid hormone action, we consider the effects on DIO1 to be of physiological importance and functional relevance. DIO1 is a well-established endpoint of T 3 action in vivo, as indicated by studies in different animal model systems (mouse, rat) and under hyperthyroid conditions in humans (König, 2005) . The effects of T 3 , GC-1, and NH-3 on DIO1 expression were similar to their corresponding effects in the reporter assay (Figs. 5A, 5B) . The T3-dependence of endogenous DIO1 was highlighted by its robust increase at all T3-concentrations tested, whereas the exerted effects were smaller than obtained in the reporter gene assay. These findings verify the sensitivity of the new assay and the differences might be attributable to the overexpression of the transfected reporter gene, the optimized TRE driving its expression and the increased TR concentration after cotransfection. F21388 and TBBPA acted as mixed agonists/antagonists in the reporter gene assays but they had a purely antagonistic effect on T3-induced DIO1 expression (Figs. 5A , 5B). 4MBC was of agonistic effect when incubated alone (Fig. 5A ), in agreement with its effects in the reporter gene assay (Fig. 4C) . In both systems, 4MBC acted as an antagonist in the T 3 competition experiments (Fig. 5B) .
The novel screening assay reported in the present work allows for large scale screening of potential ED interfering with T 3 -regulated gene expression. This assay has been optimized for a high sensitivity and a wide dynamic range and faithfully detects TR selective ligand properties of T 3 analogues. We have now screened and compared > 20 test substances contained in food, used as UV-absorber in sunscreens, cosmetics or plastics, pesticides, and industrial chemicals. As with every model or test system, also our in vitro assay has some limitation in assessing potential health risks of test compounds when used alone because it exploits TR-overexpressing cells and a bona fide TRE-driven reporter gene. Thus, observed effects of ED in this model might be much stronger than those exerted on weaker TRE of natural T 3 -target genes on background of endogenous levels of TR expression in vivo. Under serum free conditions the EC 50 of T 3 was approximately one order of magnitude lower as compared with using culture medium containing 10% hormone-reduced serum ( Supplementary Fig. 5 ). Therefore our assay is based on serum free conditions. Because some ED are known to interact and bind to serum proteins, our assay might overestimate the concentrations which are actually required in vivo for the interference with TR-controlled gene transcription. Previous studies in our and other laboratories revealed, that TTR is the most avid serum binder for several natural plant-derived polyphenolic ED (Radovic et al., 2006) . However, most of those ED agents tested here, with exception of F21388, GEN, and its glycosides, show rather poor binding to TTR and serum. In our view, this in vitro screening assay is not suited to directly estimate any risk or hazard of the tested ED for living organisms due to the complexity of ED uptake, bioconversion, serum protein binding, transmembrane transport, or excretion pathways. But in conjunction with analytical assays and respective data on the final concentrations of accumulated ED in the different human tissues and body liquids, this assay might be helpful to either dismiss some ED from further screening for TR interaction or to intensify its analysis in different test systems. 
